Quick Answer
Adagene Inc. reported Cash and Equivalents of $85.19 million for fiscal year 2024.
Adagene Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $85.19M | -22.5% |
| 2023 | $109.93M | -23.5% |
| 2022 | $143.76M | -17.6% |
| 2021 | $174.39M | +132.1% |
| 2020 | $75.15M | -18.8% |
| 2019 | $92.53M | — |
- Adagene Inc. showed a decrease of -22.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2024 period, Adagene Inc.’s cash and equivalents has declined by 7.9% (from $92.53 million to $85.19 million).
- The most recent figure is from Adagene Inc.’s fiscal year 2024 report (Form 20-F), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: